Clinical spectrum and relevance of Mycobacterium malmoense: Systematic review and meta-analysis of 859 patients

IF 14.3 1区 医学 Q1 INFECTIOUS DISEASES Journal of Infection Pub Date : 2024-06-19 DOI:10.1016/j.jinf.2024.106203
Nils Wetzstein , Victor Naestholt Dahl , Troels Lillebaek , Christoph Lange
{"title":"Clinical spectrum and relevance of Mycobacterium malmoense: Systematic review and meta-analysis of 859 patients","authors":"Nils Wetzstein ,&nbsp;Victor Naestholt Dahl ,&nbsp;Troels Lillebaek ,&nbsp;Christoph Lange","doi":"10.1016/j.jinf.2024.106203","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>The clinical relevance of <em>Mycobacterium malmoense</em> isolation from pulmonary specimens has been considered high compared with other non-tuberculous mycobacteria. In this study, we aimed to analyse all published clinical data of patients with <em>M. malmoense</em> isolation to investigate the clinical spectrum, relevance, and outcomes of infections with this uncommon mycobacterium.</p></div><div><h3>Methods</h3><p>A systematic review of PubMed, Web of Science, Embase, and Scopus was performed to identify all clinical data about <em>M. malmoense</em>. Random effects meta-analyses of proportions were calculated for clinical relevance, treatment success, and mortality, as well as for other clinical characteristics. A logistic regression analysis, investigating predictors of mortality, as well as Kaplan-Meier survival analyses, were performed.</p></div><div><h3>Results</h3><p>One hundred and eighty eight patients with individual data from 112 articles and 671 patients with pooled data from 12 articles were included in the meta-analyses. Of patients with individual data, pulmonary infection was the most common manifestation (n = 106/188, 56.4%). One third (n = 61/188, 32.4%) suffered from isolated extra-pulmonary and 21/188 (11.2%) from disseminated disease. In 288 patients with pooled data and pulmonary affection, clinical relevance was high with 68% (95% CI 44–85%) of patients fulfilling criteria for clinical disease. Macrolide and rifamycin-containing regimens were associated with improved survival (adjusted OR 0.12, 95% CI 0.03–0.42, p = 0.002, and 0.23, 95% CI 0.04–0.86, p = 0.03, for lethal events, respectively).</p></div><div><h3>Conclusion</h3><p>In this study, we provide a detailed clinical description of <em>M. malmoense</em> infections. The pathogen is of high clinical relevance for the individual patient with more than 2 out of 3 patients having relevant disease and &gt;40% of manifestations being extra-pulmonary or disseminated. Macrolide and rifamycin-containing regimens are associated with improved survival.</p></div>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":null,"pages":null},"PeriodicalIF":14.3000,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0163445324001373/pdfft?md5=d83d1e09dea2a4d86b5837f91075e1c4&pid=1-s2.0-S0163445324001373-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0163445324001373","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

The clinical relevance of Mycobacterium malmoense isolation from pulmonary specimens has been considered high compared with other non-tuberculous mycobacteria. In this study, we aimed to analyse all published clinical data of patients with M. malmoense isolation to investigate the clinical spectrum, relevance, and outcomes of infections with this uncommon mycobacterium.

Methods

A systematic review of PubMed, Web of Science, Embase, and Scopus was performed to identify all clinical data about M. malmoense. Random effects meta-analyses of proportions were calculated for clinical relevance, treatment success, and mortality, as well as for other clinical characteristics. A logistic regression analysis, investigating predictors of mortality, as well as Kaplan-Meier survival analyses, were performed.

Results

One hundred and eighty eight patients with individual data from 112 articles and 671 patients with pooled data from 12 articles were included in the meta-analyses. Of patients with individual data, pulmonary infection was the most common manifestation (n = 106/188, 56.4%). One third (n = 61/188, 32.4%) suffered from isolated extra-pulmonary and 21/188 (11.2%) from disseminated disease. In 288 patients with pooled data and pulmonary affection, clinical relevance was high with 68% (95% CI 44–85%) of patients fulfilling criteria for clinical disease. Macrolide and rifamycin-containing regimens were associated with improved survival (adjusted OR 0.12, 95% CI 0.03–0.42, p = 0.002, and 0.23, 95% CI 0.04–0.86, p = 0.03, for lethal events, respectively).

Conclusion

In this study, we provide a detailed clinical description of M. malmoense infections. The pathogen is of high clinical relevance for the individual patient with more than 2 out of 3 patients having relevant disease and >40% of manifestations being extra-pulmonary or disseminated. Macrolide and rifamycin-containing regimens are associated with improved survival.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
恶性分枝杆菌的临床谱系和相关性:对 859 名患者的系统回顾和荟萃分析。
导言:与其他非结核分枝杆菌相比,从肺部标本中分离出的恶性分枝杆菌被认为具有很高的临床意义。在本研究中,我们旨在分析所有已发表的关于分离出malmoense分枝杆菌患者的临床数据,以研究这种不常见分枝杆菌感染的临床范围、相关性和结果:方法:对PubMed、Web of Science、Embase和Scopus进行了系统性回顾,以确定所有关于M. malmoense的临床数据。对临床相关性、治疗成功率、死亡率以及其他临床特征进行了随机效应荟萃分析。对死亡率的预测因素进行了逻辑回归分析,并进行了卡普兰-梅耶生存分析:荟萃分析纳入了112篇文章中188名患者的个人数据和12篇文章中671名患者的集合数据。在有个体数据的患者中,肺部感染是最常见的表现(n=106/188,56.4%)。三分之一(n=61/188,32.4%)的患者患有孤立的肺外感染,21/188(11.2%)的患者患有播散性疾病。在汇集数据的288例肺部感染患者中,68%(95% CI 44-85%)的患者符合临床疾病标准,临床相关性很高。含大环内酯和利福霉素的治疗方案与生存率的提高有关(致死事件的调整OR值分别为0.12,95% CI 0.03-0.42,p=0.002和0.23,95% CI 0.04-0.86,p=0.03):在这项研究中,我们对M. malmoense感染进行了详细的临床描述。该病原体与个别患者的临床相关性很高,每3名患者中就有2名以上患有相关疾病,40%以上的表现为肺外或播散。含大环内酯类和利福霉素的治疗方案可提高存活率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Infection
Journal of Infection 医学-传染病学
CiteScore
45.90
自引率
3.20%
发文量
475
审稿时长
16 days
期刊介绍: The Journal of Infection publishes original papers on all aspects of infection - clinical, microbiological and epidemiological. The Journal seeks to bring together knowledge from all specialties involved in infection research and clinical practice, and present the best work in the ever-changing field of infection. Each issue brings you Editorials that describe current or controversial topics of interest, high quality Reviews to keep you in touch with the latest developments in specific fields of interest, an Epidemiology section reporting studies in the hospital and the general community, and a lively correspondence section.
期刊最新文献
Clinical Profile of Herpes Zoster-related Hospitalizations and Complications: A French Population-Based Database Study. Genomic analysis confirmed the importation of first mPox Clade Ib case in Kerala, India from Dubai, UAE. Characterization of a novel HIV-1 second-generation circulating recombinant form (CRF172_0755) among men who have sex with men in China. Near real-time severe acute respiratory illness surveillance characterising influenza and COVID-19 epidemiology in hospitalised adults, 2021-22 Global Meningococcal Initiative: Insights on antibiotic resistance, control strategies and advocacy efforts in Western Europe.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1